Novel Design Strategies for Effective Next-Generation Nuclear Localization Signal (NLS)-Therapeutics

Creative Biolabs has invited Dr. Jeffrey Leyton to describe the need to develop a more precise method in investigating nuclear transport dynamics of NLS-therapeutics. Moreover, Dr. Leyton will also present a de novo approach for generating novel NLSs with an atypical zero net-charge and evaluating various strategies to determine the worth for integration into NLS-therapeutics development.